EMvision Medical Devices (ASX:EMV) GF Score: 33/100 (As of Jul. 01, 2026) — 18% Above Median


ASX:EMV EMvision Medical Devices Ltd ASX:EMV
33 GF Score
Price A$1.49
! 3 Warning Signs
View Full Analysis

What is EMvision Medical Devices GF Score?

EMvision Medical Devices ASX:EMV -1.65% 33 GF Score is 33 as of Jul. 01, 2026, which is 18% above its 10-year median of 28.00. GuruFocus rates ASX:EMV with a GF Score™ of 33/100. The stock has 3 warning signs investors should review.

EMvision Medical Devices has the GF Score of 33, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 6/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 5/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes EMvision Medical Devices might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

EMvision Medical Devices  (ASX:EMV) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

EMvision Medical Devices GF Score Related Terms

ASX:EMV vs ABT, SYK, MDT: GF Score Comparison

For the Medical Devices subindustry, EMvision Medical Devices's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EMvision Medical Devices GF Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, EMvision Medical Devices's GF Score distribution charts can be found below:

* The bar in red indicates where EMvision Medical Devices's GF Score falls into.


ASX:EMV
33GF Score
EMvision Medical Devices Ltd ASX:EMV
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 33 mean?
EMvision Medical Devices (ASX:EMV) has a GF Score of 33 as of Jul. 01, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on EMvision Medical Devices and its competitors. This is 18% above median its historical median of 28.00. Over the past decade, EMvision Medical Devices' GF Score has ranged from 3.00 to 38.00.
Is EMvision Medical Devices' GF Score too high?
EMvision Medical Devices' current GF Score of 33 is 18% above median its 10-year median of 28.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 38.00. Overall, EMvision Medical Devices has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' GF Score compare to ABT and SYK?
EMvision Medical Devices' GF Score of 33 can be compared against companies in the Medical Devices & Instruments industry. Historically, EMvision Medical Devices' own GF Score has ranged from 3.00 to 38.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on EMvision Medical Devices and its competitors. EMvision Medical Devices's current GF Score is 33, which is 18% above median its own 10-year median of 28.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current GF Score of 33. The current GF Score is 33, which is 18% above median its 10-year median of 28.00. EMvision Medical Devices' overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current GF Score is 33 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EMvision Medical Devices Business Description

Address 65 Epping Road, Suite 4.01, Macquarie Park, Sydney, NSW, AUS, 2113
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
33GF Score

Get the complete analysis for ASX:EMV

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.49
Price